查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1157862

全球醫藥凍乾市場分析 (2023-2033)

Lyophilisation in Pharmaceutical Market Report 2023-2033
出版日期: | 出版商: Visiongain | 英文 260 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2022 年，全球醫藥冷凍乾燥市場規模將達到 2528 億美元，在預測期內（2023-2033 年）以 13.0% 的複合年增長率增長。

快餐消費、飲酒和吸煙等生活方式的改變會增加慢性病的患病率。因此，對先進藥物和治療方案的需求不斷增加，這有望在未來推動藥物冷凍乾燥市場的增長。

本報告分析了全球醫藥冷凍乾燥市場，概述了產品、基本市場結構和最新發展、關鍵驅動和製約因素，以及市場規模的估計和預測（2023-2023。2033） 、藥物類型、給藥方式、適應症、包裝和地區、主要國家的詳細趨勢、主要公司概況、COVID-19 影響和恢復情景。我會的。

內容

第一章分析概述

第 2 章執行摘要

第 3 章市場概述

  • 主要分析結果
  • 市場動態
  • 新型冠狀病毒病 (COVID-19) 的影響分析
  • 波特的五力分析
  • 害蟲分析

第 4 章藥物凍乾市場：按藥物類型分類

  • 主要分析結果
  • 市場吸引力指數：按藥物類型
  • 市場估計和預測：按藥物類型
  • 抗感染
    • 按地區劃分的市場規模（單位：十億美元，2023-2033 年）
    • 各地區的市場份額（2023 年至 2033 年）
  • 抗腫瘤藥物
  • 抗凝劑
  • 荷爾蒙
  • 抗心律失常藥
  • 其他

第 5 章藥物凍乾市場：按交付方式

  • 主要分析結果
  • 市場吸引力指數：按交付方式
  • 市場估計和預測：按交付方式
  • 預裝稀釋劑注射器
  • 多級設備

第 6 章藥物凍乾市場：按適應症分類

  • 主要分析結果
  • 市場吸引力指數：按適應症分類
  • 市場估計和預測：按指示
  • 自身免疫性疾病
  • 呼吸系統疾病
  • 消化系統疾病
  • 腫瘤
  • 心血管疾病
  • 感染
  • 代謝性疾病
  • 其他

第 7 章藥物凍乾市場：按包裝

  • 主要分析結果
  • 市場吸引力指數：按包裝分類
  • 市場估計和預測：按包裝分類
  • 小瓶
  • 墨盒
  • 填充設備

第 8 章醫藥凍乾市場：按地區

  • 主要分析結果
  • 市場吸引力指數：按地區
  • 市場估計和預測

第九章：北美醫藥冷凍乾燥市場

  • 主要分析結果
  • 市場吸引力指數
  • 市場規模：按國家/地區（單位：十億美元，2023 年、2028 年、2033 年）
  • 市場規模的估計和預測：按國家/地區
  • 市場規模估計和預測：按藥物應用
  • 市場規模的估計和預測：按交付方式
  • 市場規模的估計和預測：按指示
  • 市場規模的估計和預測：按包裝
  • 美國市場
  • 加拿大市場

第十章歐洲醫藥凍乾市場

  • 主要分析結果
  • 市場吸引力指數
  • 市場規模：按國家/地區（單位：十億美元，2023 年、2028 年、2033 年）
  • 市場規模的估計和預測：按國家/地區
  • 市場規模估計和預測：按藥物應用
  • 市場規模的估計和預測：按交付方式
  • 市場規模的估計和預測：按指示
  • 市場規模的估計和預測：按包裝
  • 德國市場
  • 法國市場
  • 英國市場
  • 意大利市場
  • 西班牙市場
  • 俄羅斯市場
  • 其他歐洲國家/地區的市場

第11章亞太醫藥凍乾市場

  • 主要分析結果
  • 市場吸引力指數
  • 市場規模的估計和預測：按國家/地區
  • 市場規模估計和預測：按藥物應用
  • 市場規模的估計和預測：按交付方式
  • 市場規模的估計和預測：按指示
  • 市場規模的估計和預測：按包裝
  • 日本市場
  • 中國市場
  • 印度市場
  • 澳大利亞市場
  • 韓國市場
  • 其他亞太國家/地區的市場

第 12 章拉丁美洲醫藥凍乾市場

  • 主要分析結果
  • 市場吸引力指數
  • 市場規模：按國家/地區（單位：十億美元，2023 年、2028 年、2033 年）
  • 市場規模的估計和預測：按國家/地區
  • 市場規模估計和預測：按藥物應用
  • 市場規模的估計和預測：按交付方式
  • 市場規模的估計和預測：按指示
  • 市場規模的估計和預測：按包裝
  • 巴西市場
  • 墨西哥市場
  • 其他拉丁美洲國家/地區的市場

第 13 章：中東和非洲的醫藥冷凍乾燥市場

  • 主要分析結果
  • 市場吸引力指數
  • 市場規模：按國家/地區（單位：十億美元，2023 年、2028 年、2033 年）
  • 市場規模的估計和預測：按國家/地區
  • 市場規模估計和預測：按藥物應用
  • 市場規模的估計和預測：按交付方式
  • 市場規模的估計和預測：按指示
  • 市場規模的估計和預測：按包裝
  • 海灣合作委員會 (GCC) 國家市場
  • 南非市場
  • 其他中東和非洲國家/地區的市場

第14章公司簡介

  • 競爭格局（2021 年）
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Novo Nordisk A/S
  • Sanofi
  • Aurobindo Pharma
  • Fresenius SE &Co. KGaA（Fresenius Kabi）
  • Merck &Co., Inc
  • Zydus Group
  • Vetter Pharma
  • F. Hoffmann-La Roche Ltd
  • Takeda Pharmaceuticals Company Limited
  • Johnson &Johnson Services Inc.
  • Cipla Inc.

第15章 結論與建議

Product Code: PHA1203

The lyophilization in pharmaceuticals market is valued at US$252.8 billion in 2022 and is projected to grow at a CAGR of 13.0% during the forecast period 2023-2033.

“The Lyophilisation in Pharmaceutical Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Prevalence of Chronic Diseases and Growing Number of Product Approvals Driving Market Growth

Lifestyle changes such as consumption of fast food, alcohol and tobacco smoking will increase the prevalence of chronic diseases. With the increasing number of people suffering from chronic conditions, there will be more demand for advanced drugs and treatment options, hence driving lyophilization in pharmaceuticals market growth in the future.

A majority of market players in the industry has a strong pipeline of drugs ready to hit the market. This resulted in increased number of product approvals over recent years. Several clinical studies are being undertaken by various organizations to secure product approval for extended application of lyophilization in pharmaceuticals to treat cancer and other diseases. With such continuous product approvals and increasing healthcare expenditure, the industry will experience robust growth in the future.

Increasing Demand for Stable Drug Formulations with Longer Shelf Life to Boost Industry Growth

Growing focus on development of freeze dried formulations is encouraging pharmaceutical companies to produce more stable products through lyophilization. Longer shelf-life and stability are of critical importance in the area of pharmaceuticals, biotechnology, bio-medical and bio-processing. Drug products are more stable in a dry state and enhances longer shelf-life, often as long as two to five years, making much easier to transport the product. The demand for lyophilization in pharmaceuticals is expected to grow significantly and will provide lucrative growth opportunity for the companies operating in this sector.

Substantial Number of Product Recalls Likely to Hamper Market Growth

Rising number of product recalls in the recent times may impede the growth in lyophilization in pharmaceuticals market. The U.S.FDA recently issued product recall notice to three lots of drugs from Sun Pharmaceutical Industries due to presence of glass particles in these drug lots. Furthermore, a significant increase in the number of recalls by market players due to adverse effects, the presence of foreign substances, among others may hamper the market growth.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the lyophilization in pharmaceuticals market evolving?
  • What is driving and restraining the lyophilization in pharmaceuticals market?
  • How will each lyophilization in pharmaceuticals submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each lyophilization in pharmaceuticals submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading lyophilization in pharmaceuticals markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the lyophilization in pharmaceuticals projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of lyophilization in pharmaceuticals projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the lyophilization in pharmaceuticals market?
  • Where is the lyophilization in pharmaceuticals market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Lyophilization in Pharmaceuticals Market today, and over the next 10 years:

  • Our 260- page report provides 114 tables and 183 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Lyophilization in Pharmaceuticals Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Drug Type

  • Anti-infective
  • Anti-neoplastic
  • Anticoagulant
  • Hormones
  • Antiarrhythmic
  • Others

Type of Delivery

  • Prefilled Diluent Syringes
  • Multi-step Devices

Indication

  • Autoimmune Diseases
  • Respiratory Diseases
  • Gastrointestinal Disorders
  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Metabolic Disorders
  • Others

Packaging

  • Vials
  • Cartridges
  • Prefilled Devices

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Lyophilization in Pharmaceuticals Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Aurobindo Pharma
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Fresenius Kabi AG
  • Gilead Sciences, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Vetter Pharma
  • Zydus Group

Overall world revenue for Lyophilization in Pharmaceuticals Market, 2023 to 2033 in terms of value the market will surpass US$282 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Lyophilization in Pharmaceuticals Market, 2023 to 2033 report help you?

In summary, our 260- page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Lyophilization in Pharmaceuticals Market, 2023 to 2033 Market, with forecasts for drug type, type of delivery, indication and packaging, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 16 key national markets - See forecasts for the Lyophilization in Pharmaceuticals Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles of the major companies involved in the Lyophilization in Pharmaceuticals Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Lyophilization in Pharmaceuticals Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Lyophilization in Pharmaceuticals Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing Prevalence of Chronic Diseases
      • 3.2.1.2 Growing Number of Product Approvals for Lyophilized Pharmaceuticals
      • 3.2.1.3 Technological Advancements in Lyophilized Drug Development
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Substantial Number of Product Recalls
      • 3.2.2.2 High Cost of Manufacturing Lyophilized Pharmaceuticals
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Growing Research and Development Activities in the Industry
      • 3.2.3.2 Increased Demand for Lyophilization of Products in Pharmaceutical and Biotech Industry
      • 3.2.3.3 Growing Demand for Superior Products with Longer Shelf Life and Stability
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Lyophilization in Pharmaceuticals Market Analysis by Drug Type

  • 4.1 Key Findings
  • 4.2 Drug Type Segment: Market Attractiveness Index
  • 4.3 Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Drug Type
  • 4.4 Anti-infective
    • 4.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Antineoplastic
    • 4.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6 Anticoagulant
    • 4.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.6.2 Market Share by Region, 2023 & 2033 (%)
  • 4.7 Hormones
    • 4.7.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.7.2 Market Share by Region, 2023 & 2033 (%)
  • 4.8 Antiarrhythmic
    • 4.8.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.8.2 Market Share by Region, 2023 & 2033 (%)
  • 4.9 Others
    • 4.9.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.9.2 Market Share by Region, 2023 & 2033 (%)

5 Lyophilization in Pharmaceuticals Market Analysis by Type of Delivery

  • 5.1 Key Findings
  • 5.2 Type of Delivery Segment: Market Attractiveness Index
  • 5.3 Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Type of Delivery
  • 5.4 Prefilled Diluent Syringes
    • 5.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Multi-step Devices
    • 5.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)

6 Lyophilization in Pharmaceuticals Market Analysis by Indication

  • 6.1 Key Findings
  • 6.2 Indication Segment: Market Attractiveness Index
  • 6.3 Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Indication
  • 6.4 Autoimmune Diseases
    • 6.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Respiratory Diseases
    • 6.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Gastrointestinal Diseases
    • 6.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Oncology
    • 6.7.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)
  • 6.8 Cardiovascular Diseases
    • 6.8.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.8.2 Market Share by Region, 2023 & 2033 (%)
  • 6.9 Infectious Diseases
    • 6.9.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.9.2 Market Share by Region, 2023 & 2033 (%)
  • 6.10 Metabolic Diseases
    • 6.10.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.10.2 Market Share by Region, 2023 & 2033 (%)
  • 6.11 Others
    • 6.11.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.11.2 Market Share by Region, 2023 & 2033 (%)

7 Lyophilization in Pharmaceuticals Market Analysis by Packaging

  • 7.1 Key Findings
  • 7.2 Packaging Segment: Market Attractiveness Index
  • 7.3 Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Packaging
  • 7.4 Vials
    • 7.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Cartridges
    • 7.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Prefilled devices
    • 7.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)

8 Lyophilization in Pharmaceuticals Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Segment: Market Attractiveness Index
  • 8.3 Lyophilization in Pharmaceuticals Market Size Estimation and Forecast

9 North America Lyophilization in Pharmaceuticals Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Lyophilization in Pharmaceuticals Market Attractiveness Index
  • 9.3 North America Lyophilization in Pharmaceuticals Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 9.4 North America Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Country
  • 9.5 North America Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Drug Type
  • 9.6 North America Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Type of Delivery
  • 9.7 North America Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Indication
  • 9.8 North America Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Packaging
  • 9.9 U.S. Lyophilization in Pharmaceuticals Market Analysis
  • 9.10 Canada Lyophilization in Pharmaceuticals Market Analysis

10 Europe Lyophilization in Pharmaceuticals Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Lyophilization in Pharmaceuticals Market Attractiveness Index
  • 10.3 Europe Lyophilization in Pharmaceuticals Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 10.4 Europe Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Country
  • 10.5 Europe Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Drug Type
  • 10.6 Europe Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Type of Delivery
  • 10.7 Europe Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Indication
  • 10.8 Europe Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Packaging
  • 10.9 Germany Lyophilization in Pharmaceuticals Market Analysis
  • 10.10 France Lyophilization in Pharmaceuticals Market Analysis
  • 10.11 UK Lyophilization in Pharmaceuticals Market Analysis
  • 10.12 Italy Lyophilization in Pharmaceuticals Market Analysis
  • 10.13 Spain Lyophilization in Pharmaceuticals Market Analysis
  • 10.14 Russia Lyophilization in Pharmaceuticals Market Analysis
  • 10.15 Rest of Europe Lyophilization in Pharmaceuticals Market Analysis

11 Asia Pacific Lyophilization in Pharmaceuticals Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Lyophilization in Pharmaceuticals Market Attractiveness Index
  • 11.3 Asia Pacific Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Country
  • 11.4 Asia Pacific Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Drug Type
  • 11.5 Asia Pacific Lyophilization in Pharmaceuticals Market Analysis by Type of Delivery
  • 11.6 Asia Pacific Lyophilization in Pharmaceuticals Market Analysis by Indication
  • 11.7 Asia Pacific Lyophilization in Pharmaceuticals Market Analysis by Packaging
  • 11.8 Japan Lyophilization in Pharmaceuticals Market Analysis
  • 11.9 China Lyophilization in Pharmaceuticals Market Analysis
  • 11.10 India Lyophilization in Pharmaceuticals Market Analysis
  • 11.11 Australia Lyophilization in Pharmaceuticals Market Analysis
  • 11.12 South Korea Lyophilization in Pharmaceuticals Market Analysis
  • 11.13 Rest of Asia Pacific Lyophilization in Pharmaceuticals Market Analysis

12 Latin America Lyophilization in Pharmaceuticals Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Lyophilization in Pharmaceuticals Market Attractiveness Index
  • 12.3 Latin America Lyophilization in Pharmaceuticals Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 12.4 Latin America Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Country
  • 12.5 Latin America Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Drug Type
  • 12.6 Latin America Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Type of Delivery
  • 12.7 Latin America Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Indication
  • 12.8 Latin America Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Packaging
  • 12.9 Brazil Lyophilization in Pharmaceuticals Market Analysis
  • 12.10 Mexico Lyophilization in Pharmaceuticals Market Analysis
  • 12.11 Rest of Latin America Lyophilization in Pharmaceuticals Market Analysis

13 MEA Lyophilization in Pharmaceuticals Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Lyophilization in Pharmaceuticals Market Attractiveness Index
  • 13.3 MEA Lyophilization in Pharmaceuticals Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 13.4 MEA Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Country
  • 13.5 MEA Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Drug Type
  • 13.6 MEA Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Type of Delivery
  • 13.7 MEA Lyophilization in Pharmaceuticals Market Size Estimation and Forecast by Indication
  • 13.8 MEA Lyophilization in Pharmaceuticals Market Analysis by Packaging
  • 13.9 GCC Lyophilization in Pharmaceuticals Market Analysis
  • 13.10 South Africa Lyophilization in Pharmaceuticals Market Analysis
  • 13.11 Rest of MEA Lyophilization in Pharmaceuticals Market Analysis

14 Company Profiles

  • 14.1 Competitive Landscape, 2021
  • 14.2 Bristol-Myers Squibb Company
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis
      • 14.2.3.1 Net Revenue, 2017-2021
      • 14.2.3.2 R&D, 2017-2021
      • 14.2.3.3 Regional Market Shares, 2021
    • 14.2.4 Product Benchmarking
    • 14.2.5 Strategic Outlook
  • 14.3 Gilead Sciences, Inc.
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2017-2021
      • 14.3.3.2 R&D, 2017-2021
      • 14.3.3.3 Regional Market Shares, 2021
    • 14.3.4 Product Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 Novo Nordisk A/S
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
      • 14.4.3.1 Net Revenue, 2017-2021
      • 14.4.3.2 R&D, 2017-2021
      • 14.4.3.3 Regional Market Shares, 2021
    • 14.4.4 Product Benchmarking
    • 14.4.5 Strategic Outlook
  • 14.5 Sanofi
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
      • 14.5.3.1 Net Revenue, 2017-2021
      • 14.5.3.2 R&D, 2017-2021
      • 14.5.3.3 Regional Market Shares, 2021
    • 14.5.4 Product Benchmarking
    • 14.5.5 Strategic Outlook
  • 14.6 Aurobindo Pharma
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
      • 14.6.3.1 Net Revenue, 2017-2021
      • 14.6.3.2 R&D, 2017-2021
      • 14.6.3.3 Regional Market Shares, 2021
    • 14.6.4 Product Benchmarking
    • 14.6.5 Strategic Outlook
  • 14.7 Fresenius SE & Co. KGaA (Fresenius Kabi)
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
      • 14.7.3.1 Net Revenue, 2017-2021
      • 14.7.3.2 R&D, 2017-2021
      • 14.7.3.3 Regional Market Shares, 2021
    • 14.7.4 Product Benchmarking
    • 14.7.5 Strategic Outlook
  • 14.8 Merck & Co., Inc
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2017-2021
      • 14.8.3.2 R&D, 2017-2021
      • 14.8.3.3 Regional Market Shares, 2021
    • 14.8.4 Product Benchmarking
    • 14.8.5 Strategic Outlook
  • 14.9 Zydus Group
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2017-2021
      • 14.9.3.2 R&D, 2017-2021
      • 14.9.3.3 Regional Market Shares, 2021
    • 14.9.4 Product Benchmarking
    • 14.9.5 Strategic Outlook
  • 14.10 Vetter Pharma
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2017-2021
    • 14.10.4 Product Benchmarking
    • 14.10.5 Strategic Outlook
  • 14.11 F. Hoffmann-La Roche Ltd
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
      • 14.11.3.1 Net Revenue, 2017-2021
      • 14.11.3.2 R&D, 2017-2021
      • 14.11.3.3 Regional Market Shares, 2021
    • 14.11.4 Product Benchmarking
    • 14.11.5 Strategic Outlook
  • 14.12 Takeda Pharmaceuticals Company Limited
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
      • 14.12.3.1 Net Revenue, 2017-2021
      • 14.12.3.2 R&D, 2017-2021
      • 14.12.3.3 Regional Market Shares, 2021
    • 14.12.4 Product Benchmarking
    • 14.12.5 Strategic Outlook
  • 14.13 Johnson & Johnson Services Inc.
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
      • 14.13.3.1 Net Revenue, 2017-2021
      • 14.13.3.2 R&D, 2017-2021
      • 14.13.3.3 Regional Market Shares, 2021
    • 14.13.4 Product Benchmarking
    • 14.13.5 Strategic Outlook
  • 14.14 Cipla Inc.
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Financial Analysis
      • 14.14.3.1 Net Revenue, 2017-2021
      • 14.14.3.2 R&D, 2017-2021
      • 14.14.3.3 Regional Market Shares, 2021
    • 14.14.4 Product Benchmarking
    • 14.14.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 Lyophilization in Pharmaceuticals Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
  • Table 2 Lyophilization in Pharmaceuticals Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR(%)): "V" Shaped Recovery Scenario
  • Table 3 Lyophilization in Pharmaceuticals Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR(%)): "U" Shaped Recovery Scenario
  • Table 4 Lyophilization in Pharmaceuticals Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR(%)): "W" Shaped Recovery Scenario
  • Table 5 Lyophilization in Pharmaceuticals Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR(%)): "L" Shaped Recovery Scenario
  • Table 6 Lyophilization in Pharmaceuticals Market by Drug Type, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 7 Anti-infective Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 8 Anti-neoplastic Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 9 Anticoagulant Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 10 Hormones Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 11 Antiarrhythmic Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 12 Others Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 13 Lyophilization in Pharmaceuticals Market by Type of Delivery, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 14 Prefilled Diluent Syringes Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 15 Multistep devices Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 16 Lyophilization in Pharmaceuticals Market by Indication, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 17 Auto-Immune Diseases Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 18 Respiratory Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 19 Gastrointestinal Diseases Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 20 Oncology Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 21 Cardiovascular Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 22 Infections Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 23 Metabolic Disorders Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 24 Others Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 25 Lyophilization in Pharmaceuticals Market by Packaging, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 26 Vials Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 27 Cartridges Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 28 Prefilled Devices Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 29 Lyophilization in Pharmaceuticals Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 30 North America Lyophilization in Pharmaceuticals Forecast by Country
  • Table 31 North America Lyophilization in Pharmaceuticals Market by Drug Type, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 32 Lyophilization in Pharmaceuticals Market by Type of Delivery, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 33 Lyophilization in Pharmaceuticals Market by Indications, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 34 Lyophilization in Pharmaceuticals Market by Packaging, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 35 U.S. Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR %, CAGR %)
  • Table 36 Canada Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR %, CAGR %)
  • Table 37 Europe Lyophilization in Pharmaceuticals Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 38 Europe Lyophilization in Pharmaceuticals Market by Drug Type, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 39 Europe Lyophilization in Pharmaceuticals Market by Type of delivery, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 40 Europe Lyophilization in Pharmaceuticals Market by Indications, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 41 Europe Lyophilization in Pharmaceuticals Market by Packaging, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 42 Germany Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 43 France Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 44 UK Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 45 Italy Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 46 Spain Lyophilization in Pharmaceuticals Market Forecast by Country: 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 47 Russia Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 48 Rest of Europe Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 49 Asia Pacific Lyophilization in Pharmaceuticals forecast by Country 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 50 Asia Pacific Lyophilization in Pharmaceuticals Market by Drug Type, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 51 Asia Pacific in Pharmaceuticals Market by Type of Delivery, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 52 Asia Pacific Lyophilization in Pharmaceuticals Market by Indication, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 53 Asia Pacific Lyophilization in Pharmaceuticals Market by Packaging, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 54 Japan Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 55 China Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 56 India Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 57 Australia Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 58 South Korea Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 59 Rest of Asia Pacific Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 60 Latin America Lyophilization in Pharmaceuticals forecast by Country 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 61 Latin America Lyophilization in Pharmaceuticals Market by Drug Type, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 62 Lyophilization in Pharmaceuticals Market by Type of Delivery, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 63 Latin America Lyophilization in Pharmaceuticals Market by Indications, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 64 Latin America Lyophilization in Pharmaceuticals Market by Packaging, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 65 Brazil Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 66 Mexico Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 67 Rest of Latin America Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 68 MEA Lyophilization in Pharmaceuticals forecast by Country 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 69 Lyophilization in Pharmaceuticals Market by Drug Type, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 70 MEA Lyophilization in Pharmaceuticals Market by Type of delivery, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 71 MEA Lyophilization in Pharmaceuticals Market by Indications, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 72 MEA Lyophilization in Pharmaceuticals Market by Packaging, 2023-2033 (US$ bn, AGR (%), CAGR(%)):
  • Table 73 GCC Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 74 South Africa Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 75 Rest of MEA Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Table 76 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 77 Bristol-Myers Squibb Company: Product Benchmarking
  • Table 78 Bristol-Myers Squibb Company: Strategic Outlook
  • Table 79 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 80 Gilead Sciences, Inc.: Product Benchmarking
  • Table 81 Gilead Sciences, Inc.: Strategic Outlook
  • Table 82 Novo Nordisk: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 Novo Nordisk, Inc.: Product Benchmarking
  • Table 84 Novo Nordisk.: Strategic Outlook
  • Table 85 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 86 Sanofi.: Product Benchmarking
  • Table 87 Sanofi.: Strategic Outlook
  • Table 88 Aurobindo Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Aurobindo Pharma: Product Benchmarking
  • Table 90 Aurobindo Pharma.: Strategic Outlook
  • Table 91 Fresenius Kabi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 Fresenius Kabi: Product Benchmarking
  • Table 93 Fresenius Kabi: Strategic Outlook
  • Table 94 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 Merck & Co., Inc.: Product Benchmarking
  • Table 96 Merck & Co., Inc.: Strategic Outlook
  • Table 97 Zydus: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Zydus.: Product Benchmarking
  • Table 99 Zydus.: Strategic Outlook
  • Table 100 Vetter Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Vetter Pharma: Product Benchmarking
  • Table 102 Vetter Pharma: Strategic Outlook
  • Table 103 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 F. Hoffmann-La Roche Ltd.: Product Benchmarking
  • Table 105 F. Hoffmann-La Roche Ltd.: Strategic Outlook
  • Table 106 Takeda: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Takeda: Product Benchmarking
  • Table 108 Takeda: Strategic Outlook
  • Table 109 Johnson & Johnson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Johnson & Johnson: Product Benchmarking
  • Table 111 Johnson & Johnson: Strategic Outlook
  • Table 112 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 Cipla Inc.: Product Benchmarking
  • Table 114 Cipla Inc.: Strategic Outlook
  •  

List of Figures

  • Figure 1 Lyophilization in Pharmaceuticals Market Segmentation
  • Figure 2 Lyophilization in Pharmaceuticals Market by Drug type: Market Attractiveness Index
  • Figure 3 Lyophilization in Pharmaceuticals Market by Type of Delivery: Market Attractiveness Index
  • Figure 4 Lyophilization in Pharmaceuticals Market by Indication: Market Attractiveness Index
  • Figure 5 Lyophilization in Pharmaceuticals Market by Packaging: Market Attractiveness Index
  • Figure 6 Lyophilization in Pharmaceuticals Market Attractiveness Index by Region
  • Figure 7 Lyophilization in Pharmaceuticals Market: Market Dynamics
  • Figure 8 COVID Impact Analysis: Lyophilization in Pharmaceuticals Market Recovery Scenarios
  • Figure 9 Lyophilization in Pharmaceuticals Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): "V" Shaped Recovery
  • Figure 10 Lyophilization in Pharmaceuticals Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): "U" Shaped Recovery
  • Figure 11 Lyophilization in Pharmaceuticals Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): "W" Shaped Recovery
  • Figure 12 Lyophilization in Pharmaceuticals Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): "L" Shaped Recovery
  • Figure 13 Lyophilization in Pharmaceuticals Market: Porter's Five Forces Analysis
  • Figure 14 Lyophilization in Pharmaceuticals Market: PEST Analysis
  • Figure 15 Lyophilization in Pharmaceuticals Market by Drug type: Market Attractiveness Index
  • Figure 16 Lyophilization in Pharmaceuticals Market Forecast by Drug Type, 2023-2033 (US$ billion)
  • Figure 17 Lyophilization in Pharmaceuticals Market Share Forecast by Drug Type, 2023, 2033 (%)
  • Figure 18 Anti-infective Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 19 Anti-infective Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 20 Antineoplastic Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 21 Antineoplastic Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 22 Anticoagulant Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 23 Anticoagulant Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 24 Hormones Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 25 Hormones Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 26 Antiarrhythmic Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 27 Antiarrhythmic Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 28 Others Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 29 Others Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 30 Lyophilization in Pharmaceuticals Market by Type of Delivery: Market Attractiveness Index
  • Figure 31 Lyophilization in Pharmaceuticals Market Forecast by Type of Delivery, 2023-2033 (US$ billion)
  • Figure 32 Lyophilization in Pharmaceuticals Market Share Forecast by Type of Delivery, 2023 & 2033 (%)
  • Figure 33 Prefilled Diluent Syringes Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 34 Prefilled Diluent Syringes Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 35 Multi-step Devices Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 36 Multi-step Devices Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 37 Lyophilization in Pharmaceuticals Market by Type of Delivery: Market Attractiveness Index
  • Figure 38 Lyophilization in Pharmaceuticals Market by Indication, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Figure 39 Lyophilization in Pharmaceuticals Market Share Forecast by Indication, 2023 & 2033 (%)
  • Figure 40 Autoimmune Diseases Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 41 Autoimmune Diseases Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 42 Respiratory Diseases Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 43 Respiratory Diseases Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 44 Gastrointestinal Diseases Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 45 Gastrointestinal Diseases Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 46 Oncology Diseases Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 47 Oncology Diseases Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 48 Cardiovascular Diseases Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 49 Cardiovascular Diseases Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 50 Infectious Diseases Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 51 Infectious Diseases Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 52 Metabolic Diseases Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 53 Metabolic Diseases Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 54 Others Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 55 Others Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 56 Lyophilization in Pharmaceuticals Market by Packaging: Market Attractiveness Index
  • Figure 57 Lyophilization in Pharmaceuticals Market by Packaging, 2023-2033 (US$ bn, AGR (%), CAGR(%))
  • Figure 58 Lyophilization in Pharmaceuticals Market Share Forecast by Packaging, 2023 & 2033 (%)
  • Figure 59 Vials Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 60 Vials Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 61 Cartridges Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 62 Cartridges Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 63 Prefilled devices Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 64 Prefilled devices Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 65 Lyophilization in Pharmaceuticals Market by Region: Market Attractiveness Index
  • Figure 66 Lyophilization in Pharmaceuticals Market by Region, 2023-2033 (US$ bn)
  • Figure 67 Lyophilization in Pharmaceuticals Market Share Forecast by Region 2023, 2033(%)
  • Figure 68 North America Lyophilization in Pharmaceuticals Market Attractiveness Index
  • Figure 69 North America Lyophilization in Pharmaceuticals Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 70 North America Lyophilization in Pharmaceuticals Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 71 North America Lyophilization in Pharmaceuticals Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 72 North America Lyophilization in Pharmaceuticals Market Forecast by Drug Type, 2023-2033 (US$ billion)
  • Figure 73 North America Lyophilization in Pharmaceuticals Market Share Forecast by Drug Type, 2023 & 2033 (%)
  • Figure 74 North America Lyophilization in Pharmaceuticals Market Forecast by Type of Delivery, 2023-2033 (US$ billion)
  • Figure 75 North America Lyophilization in Pharmaceuticals Market Share Forecast by Type of Delivery, 2023 & 2033 (%)
  • Figure 76 U.S. Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 77 North America Lyophilization in Pharmaceuticals Market Share Forecast by Indication, 2023 & 2033 (%)
  • Figure 78 North America Lyophilization in Pharmaceuticals Market Share Forecast by Packaging, 2023 & 2033 (%)
  • Figure 79 North America Lyophilization in Pharmaceuticals Market Share Forecast by Packaging, 2023 & 2033 (%)
  • Figure 80 U.S. Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 81 Canada Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 82 Europe Lyophilization in Pharmaceuticals Market Attractiveness Index
  • Figure 83 Europe Lyophilization in Pharmaceuticals Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 84 Europe Lyophilization in Pharmaceuticals Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 85 Europe Lyophilization in Pharmaceuticals Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 86 Europe Lyophilization in Pharmaceuticals Market Forecast by Drug Type, 2023-2033 (US$ billion)
  • Figure 87 Europe Lyophilization in Pharmaceuticals Market Share Forecast by Drug Type, 2023 & 2033 (%)
  • Figure 88 Europe Lyophilization in Pharmaceuticals Market Forecast by Type of Delivery, 2023-2033 (US$ billion)
  • Figure 89 Europe Lyophilization in Pharmaceuticals Market Share Forecast by Type of Delivery, 2023 & 2033 (%)
  • Figure 90 Europe Lyophilization in Pharmaceuticals Market Forecast by Indications, 2023-2033 (US$ billion, AGR %)
  • Figure 91 Europe Lyophilization in Pharmaceuticals Market Share Forecast by Indications, 2023 & 2033 (%)
  • Figure 92 Europe Lyophilization in Pharmaceuticals Market Forecast by Packaging, 2023-2033 (US$ billion, AGR %)
  • Figure 93 Europe Lyophilization in Pharmaceuticals Market Share Forecast by Packaging, 2023 & 2033 (%)
  • Figure 94 Germany Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 95 France Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 96 UK Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 97 Italy Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 98 Spain Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 99 Russia Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 100 Rest of Europe Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 101 Asia Pacific Lyophilization in Pharmaceuticals Market Attractiveness Index
  • Figure 102 Asia Pacific Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 103 Asia Pacific Lyophilization in Pharmaceuticals Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 104 Asia Pacific Lyophilization in Pharmaceuticals Market Forecast by Drug Type, 2023-2033 (US$ billion, AGR %)
  • Figure 105 Asia Pacific Lyophilization in Pharmaceuticals Market Share Forecast by Drug Type, 2023 & 2033 (%)
  • Figure 106 Asia Pacific Lyophilization in Pharmaceuticals Market Forecast by Type of Delivery, 2023-2033 (US$ billion, AGR %)
  • Figure 107 Asia Pacific Lyophilization in Pharmaceuticals Market Share Forecast by Type of Delivery, 2023 & 2033 (%)
  • Figure 108 Asia Pacific Lyophilization in Pharmaceuticals Market Forecast by Indication, 2023-2033 (US$ billion, AGR %)
  • Figure 109 Asia Pacific Lyophilization in Pharmaceuticals Market Share Forecast by Indication, 2023 & 2033 (%)
  • Figure 110 Asia Pacific Lyophilization in Pharmaceuticals Market Forecast by Packaging, 2023-2033 (US$ billion, AGR %)
  • Figure 111 Asia Pacific Lyophilization in Pharmaceuticals Market Share Forecast by Packaging, 2023 & 2033 (%)
  • Figure 112 Japan Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 113 China Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 114 India Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 115 Australia Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 116 South Korea Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 117 Rest of Asia Pacific Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 118 Latin America Lyophilization in Pharmaceuticals Market Attractiveness Index
  • Figure 119 Latin America Lyophilization in Pharmaceuticals Market by Country, 2023, 2028 & 2033 (US$ billion)
  • Figure 120 Latin America Lyophilization in Pharmaceuticals Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 121 Latin America Lyophilization in Pharmaceuticals Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 122 Latin America Lyophilization in Pharmaceuticals Market Forecast by Drug Type, 2023-2033 (US$ billion)
  • Figure 123 Latin America Lyophilization in Pharmaceuticals Market Share Forecast by Drug Type, 2023 & 2033 (%)
  • Figure 124 Latin America Lyophilization in Pharmaceuticals Market Forecast by Type of Delivery, 2023-2033 (US$ billion)
  • Figure 125 Latin America Lyophilization in Pharmaceuticals Market Share Forecast by Type of Delivery, 2023 & 2033 (%)
  • Figure 126 Latin America Lyophilization in Pharmaceuticals Market Forecast by Indications, 2023-2033 (US$ billion, AGR %)
  • Figure 127 Latin America Lyophilization in Pharmaceuticals Market Share Forecast by Indications, 2023 & 2033 (%)
  • Figure 128 Latin America Lyophilization in Pharmaceuticals Market Forecast by Packaging, 2023-2033 (US$ billion, AGR %)
  • Figure 129 Latin America Lyophilization in Pharmaceuticals Market Share Forecast by Packaging, 2023 & 2033 (%)
  • Figure 130 Brazil Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 131 Mexico Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 132 Rest of Latin America Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 133 MEA Lyophilization in Pharmaceuticals Market Attractiveness Index
  • Figure 134 MEA Lyophilization in Pharmaceuticals Market by Country, 2023, 2028 & 2033 (US$ billion)
  • Figure 135 MEA Lyophilization in Pharmaceuticals Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 136 MEA Lyophilization in Pharmaceuticals Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 137 MEA Lyophilization in Pharmaceuticals Market Forecast by Drug Type, 2023-2033 (US$ billion)
  • Figure 138 MEA Lyophilization in Pharmaceuticals Market Share Forecast by Drug Type, 2023 & 2033 (%)
  • Figure 139 MEA Lyophilization in Pharmaceuticals Market Forecast by Type of Delivery, 2023-2033 (US$ billion)
  • Figure 140 MEA Lyophilization in Pharmaceuticals Market Share Forecast by Type of Delivery, 2023 & 2033 (%)
  • Figure 141 MEA Lyophilization in Pharmaceuticals Market Indications, 2023-2033 (US$ billion, AGR %)
  • Figure 142 MEA Lyophilization in Pharmaceuticals Market Share Forecast by Indications, 2023 & 2033 (%)
  • Figure 143 MEA Lyophilization in Pharmaceuticals Market Forecast by Packaging, 2023-2033 (US$ billion, AGR %)
  • Figure 144 MEA Lyophilization in Pharmaceuticals Market Share Forecast by Packaging, 2023 & 2033 (%)
  • Figure 145 GCC Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 146 South Africa Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 147 Rest of MEA Lyophilization in Pharmaceuticals Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 148 Bristol-Myers Squibb Company: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 149 Bristol-Myers Squibb Company: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 150 Bristol-Myers Squibb Company: Regional Market Shares, 2021
  • Figure 151 Gilead Sciences, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 152 Gilead Sciences, Inc.: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 153 Gilead Sciences, Inc.: Regional Market Shares, 2021
  • Figure 154 Novo Nordisk: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 155 Novo Nordisk: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 156 Novo Nordisk: Regional Market Shares, 2021
  • Figure 157 Sanofi: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 158 Sanofi: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 159 Sanofi: Regional Market Shares, 2021
  • Figure 160 Aurobindo Pharma: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 161 Aurobindo Pharma: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 162 Aurobindo Pharma: Regional Market Shares, 2021
  • Figure 163 Fresenius Kabi: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 164 Fresenius Kabi AG: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 165 Fresenius Kabi AG: Regional Market Shares, 2021
  • Figure 166 Merck & Co., Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 167 Merck & Co., Inc.: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 168 Merck & Co., Inc.: Regional Market Shares, 2021
  • Figure 169 Zydus: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 170 Zydus: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 171 Zydus: Regional Market Shares, 2021
  • Figure 172 F. Hoffmann-La Roche Ltd: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 173 F. Hoffmann-La Roche Ltd.: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 174 F. Hoffmann-La Roche Ltd.: Regional Market Shares, 2021
  • Figure 175 Takeda: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 176 Takeda: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 177 Takeda: Regional Market Shares, 2021
  • Figure 178 Johnson & Johnson: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 179 Johnson & Johnson: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 180 Johnson & Johnson: Regional Market Shares, 2021
  • Figure 181 Cipla Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 182 Cipla Inc.: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 183 Cipla Inc.: Regional Market Shares, 2021